To assess the clinical relevance of persistent aPL in our cohort, as it is possiblethat these persistent aPL could have occurred by chance, we categorized patients in ourcohort as having high-risk or lower-risk APS as detailedin the Methods section and correlated aPL results with clinical risk. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.